Tulp; Martinus Th. M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tulp; Martinus Th. M..The latest application filed is for "combination preparations comprising slv308 and a dopamine agonist".

Company Profile

0.6.14

Tulp; Martinus Th. M. - Weesp NL
Tulp; Martinus Th.M - Weesp NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination preparations comprising bifeprunox and a dopamine agonist Grant 8,106,056 - McCreary , et al. January 31, 2	2012-01-31
Combination preparations comprising SLV308 and a dopamine agonist Grant 7,915,262 - McCreary , et al. March 29, 2	2011-03-29
Combination Preparations Comprising Slv308 And A Dopamine Agonist App 20100292248 - McCreary; Andrew C. ; et al.	2010-11-18
Combination preparations comprising SLV308 and a dopamine agonist Grant 7,786,126 - McCreary , et al. August 31, 2	2010-08-31
Muscarinic Agonists To Treat Impulse Control Disorders App 20100120752 - De Bruin; Natasja M.W.J. ; et al.	2010-05-13
N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs Grant 7,696,383 - Turski , et al. April 13, 2	2010-04-13
N-oxides Of Venlafaxine And O-desmethylvenlafaxine As Prodrugs App 20090005455 - Turski; Lechoslaw A. ; et al.	2009-01-01
Sildenafil N-oxide As Prodrug App 20090005395 - Turski; Lechoslaw A. ; et al.	2009-01-01
Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D.sub.2 receptors and serotonin reuptake sites Grant 7,371,769 - Hes , et al. May 13, 2	2008-05-13
Combination Preparations Comprising Slv308 And A Dopamine Agonist App 20070293505 - McCREARY; Andrew C. ; et al.	2007-12-20
Combination Preparations Comprising Bifeprunox And A Dopamine Agonist App 20070293506 - McCREARY; Andrew C. ; et al.	2007-12-20
Muscarinic Agonists To Treat Impulse Control Disorders App 20070259859 - De Bruin; Natasja M.W.J. ; et al.	2007-11-08
Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmission App 20060194971 - Drukarch; Benjamin ; et al.	2006-08-31
Piperazine oxime dervatives having NK-1 receptor antagonistic activity Grant 7,094,779 - Bakker , et al. August 22, 2	2006-08-22
AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorder App 20060166969 - Turski; Lechoslaw A. ; et al.	2006-07-27
Phenylpiperazines with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites App 20060122177 - Hes; Roelof van ; et al.	2006-06-08
Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites App 20060122206 - Hes; Roelof van ; et al.	2006-06-08
Benzdioxane piperazine derivatives with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites App 20060122175 - Hes; Roelof van ; et al.	2006-06-08
Neurokinin-1 receptor antagonists for the treatment of conditions responsive to testosterone elevation, including testosterone deficiency App 20060030556 - Fuchs; Eberhard K.M. ; et al.	2006-02-09
Piperazine oxime dervatives having nk-1 receptor antagonistic activity App 20040176389 - Bakker, Wouter I Ivema ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.